31.08.2013 Views

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

towards improved death receptor targeted therapy for ... - TI Pharma

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

Chapter 5<br />

targets and subsequent proteasomal degradation thus removing possible anti‐apoptotic<br />

proteins resulting in sensitization <strong>for</strong> apoptosis [15]. The small molecule, 17‐allylamino‐17‐<br />

demethoxy‐geldanamycin (17‐AAG) is a potent Hsp90 inhibitor that induces cell cycle<br />

arrest and apoptosis in a variety of tumor cells, including NSCLC [16].<br />

In this study we investigated whether 17‐AAG enhances the apoptosis‐inducing effect of<br />

TRAIL in NSCLC cells. Furthermore, the mode of action of the synergy of these two<br />

compounds was studied.<br />

MATERIALS & METHODS<br />

Cell lines and reagents<br />

The NSCLC cell lines, A549 and H460, were cultured in RPMI‐1640 supplemented with 10%<br />

Fetal Calf Serum (FCS). The cells were maintained in a humidified incubator at 37 °C and in<br />

a 5% CO2‐atmosphere. TRAIL (PeproTech EC Ltd, London, UK) was aliquoted in PBS at a<br />

final concentration of 500 ng/ml and stored at ‐20 °C. 17‐AAG was diluted in DMSO (stock<br />

solution of 1mM) and stored at ‐20 °C. The caspase inhibitors Z‐VAD‐fmk (general caspase<br />

inhibitor), Z‐IETD‐fmk (caspase‐8) and Z‐LEHD‐fmk (caspase‐9) were purchased from<br />

Bachem AG, dissolved in DMSO (10 mM or 20 mM) and stored at ‐20 °C.<br />

Drug cytotoxicity assays<br />

Drug cytotoxicity was determined using the methyl thiazole tetrazolium (MTT) assay. Cells<br />

were seeded in 96‐wells plates with a cell density of 9,000 cells/well. After 24 h, enabling<br />

attachment, cells were exposed (in triplicate) to increasing concentrations of the two<br />

drugs <strong>for</strong> 24 h. Next, the medium was removed and 50 µl MTT (10% diluted in HBSS<br />

buffer) per well was added and incubated <strong>for</strong> 1‐3 h at 37 °C. After the incubation, 150 μl<br />

DMSO per well was added and following 10‐15 min slowly shaking, the absorbance of the<br />

plate was measured at 540 nm with a TECAN plate reader by using the XFLUOR4 program.<br />

IC50 values were determined from the graphs. Synergy of TRAIL and 17‐AAG was<br />

determined by calculation of the combination index (CI) using Calcusyn (Calcusyn Biosoft,<br />

Cambridge, UK) as described earlier [17]. For calculation of the CI, only values above a<br />

fraction affected (FA) of 0.5 were used, equivalent to 50 ‐ 100% growth inhibition. A CI <<br />

0.9 indicates synergism and >1.1 antagonism.<br />

Cell cycle and cell <strong>death</strong> measurements<br />

Cells were plated at a density of 200,000 cells/well in 6‐wells plates. After 24 h enabling<br />

attachment, the medium was replaced by medium containing the drug(s) as indicated.<br />

When indicated, caspase inhibitors were added to a final concentration of 20 µM, 2 h<br />

prior to drug treatment. After drug exposure cells were trypsinized, resuspended in<br />

medium collected from the matching sample and centrifuged <strong>for</strong> 5 min at 1200 rpm. After<br />

‐ 86 ‐

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!